These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33368296)

  • 1. Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
    Lonjou C; Eon-Marchais S; Truong T; Dondon MG; Karimi M; Jiao Y; Damiola F; Barjhoux L; Le Gal D; Beauvallet J; Mebirouk N; Cavaciuti E; Chiesa J; Floquet A; Audebert-Bellanger S; Giraud S; Frebourg T; Limacher JM; Gladieff L; Mortemousque I; Dreyfus H; Lejeune-Dumoulin S; Lasset C; Venat-Bouvet L; Bignon YJ; Pujol P; Maugard CM; Luporsi E; Bonadona V; Noguès C; Berthet P; Delnatte C; Gesta P; Lortholary A; Faivre L; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Mazoyer S; Monraz LC; Kondratova M; Kuperstein I; Guénel P; Barillot E; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Int J Cancer; 2021 Apr; 148(8):1895-1909. PubMed ID: 33368296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
    Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
    J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
    Coignard J; Lush M; Beesley J; O'Mara TA; Dennis J; Tyrer JP; Barnes DR; McGuffog L; Leslie G; Bolla MK; Adank MA; Agata S; Ahearn T; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Arnold N; Aronson KJ; Arun BK; Augustinsson A; Azzollini J; Barrowdale D; Baynes C; Becher H; Bermisheva M; Bernstein L; Białkowska K; Blomqvist C; Bojesen SE; Bonanni B; Borg A; Brauch H; Brenner H; Burwinkel B; Buys SS; Caldés T; Caligo MA; Campa D; Carter BD; Castelao JE; Chang-Claude J; Chanock SJ; Chung WK; Claes KBM; Clarke CL; ; ; Collée JM; Conroy DM; Czene K; Daly MB; Devilee P; Diez O; Ding YC; Domchek SM; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Eliassen AH; Engel C; Eriksson M; Evans DG; Fasching PA; Flyger H; Fostira F; Friedman E; Fritschi L; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; Garcia-Barberan V; García-Closas M; García-Sáenz JA; Gaudet MM; Gayther SA; Gehrig A; Georgoulias V; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hart SN; He W; Hogervorst FBL; Hollestelle A; Hopper JL; Horcasitas DJ; Hulick PJ; Hunter DJ; Imyanitov EN; ; ; ; Jager A; Jakubowska A; James PA; Jensen UB; John EM; Jones ME; Kaaks R; Kapoor PM; Karlan BY; Keeman R; Khusnutdinova E; Kiiski JI; Ko YD; Kosma VM; Kraft P; Kurian AW; Laitman Y; Lambrechts D; Le Marchand L; Lester J; Lesueur F; Lindstrom T; Lopez-Fernández A; Loud JT; Luccarini C; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Mebirouk N; Meindl A; Miller A; Milne RL; Montagna M; Nathanson KL; Neuhausen SL; Nevanlinna H; Nielsen FC; O'Brien KM; Olopade OI; Olson JE; Olsson H; Osorio A; Ottini L; Park-Simon TW; Parsons MT; Pedersen IS; Peshkin B; Peterlongo P; Peto J; Pharoah PDP; Phillips KA; Polley EC; Poppe B; Presneau N; Pujana MA; Punie K; Radice P; Rantala J; Rashid MU; Rennert G; Rennert HS; Robson M; Romero A; Rossing M; Saloustros E; Sandler DP; Santella R; Scheuner MT; Schmidt MK; Schmidt G; Scott C; Sharma P; Soucy P; Southey MC; Spinelli JJ; Steinsnyder Z; Stone J; Stoppa-Lyonnet D; Swerdlow A; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Teulé A; Thull DL; Tischkowitz M; Toland AE; Torres D; Trainer AH; Truong T; Tung N; Vachon CM; Vega A; Vijai J; Wang Q; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wolk A; Yadav S; Yang XR; Yannoukakos D; Zheng W; Ziogas A; Zorn KK; Park SK; Thomassen M; Offit K; Schmutzler RK; Couch FJ; Simard J; Chenevix-Trench G; Easton DF; Andrieu N; Antoniou AC
    Nat Commun; 2021 Feb; 12(1):1078. PubMed ID: 33597508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are VNTRs co-localizing with breast cancer-associated SNPs?
    Leclerc M; Neuhausen SL; Schayek H; Laitman Y; Antonis AC; Friedman E
    Breast Cancer Res Treat; 2018 Feb; 168(1):277-281. PubMed ID: 29168065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
    Jiao Y; Truong T; Eon-Marchais S; Mebirouk N; Caputo SM; Dondon MG; Karimi M; Le Gal D; Beauvallet J; Le Floch É; Dandine-Roulland C; Bacq-Daian D; Olaso R; Albuisson J; Audebert-Bellanger S; Berthet P; Bonadona V; Buecher B; Caron O; Cavaillé M; Chiesa J; Colas C; Collonge-Rame MA; Coupier I; Delnatte C; De Pauw A; Dreyfus H; Fert-Ferrer S; Gauthier-Villars M; Gesta P; Giraud S; Gladieff L; Golmard L; Lasset C; Lejeune-Dumoulin S; Léoné M; Limacher JM; Lortholary A; Luporsi É; Mari V; Maugard CM; Mortemousque I; Mouret-Fourme E; Nambot S; Noguès C; Popovici C; Prieur F; Pujol P; Sevenet N; Sobol H; Toulas C; Uhrhammer N; Vaur D; Venat L; Boland-Augé A; Guénel P; Deleuze JF; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Eur J Cancer; 2023 Jan; 179():76-86. PubMed ID: 36509001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.
    Rinella ES; Shao Y; Yackowski L; Pramanik S; Oratz R; Schnabel F; Guha S; LeDuc C; Campbell CL; Klugman SD; Terry MB; Senie RT; Andrulis IL; Daly M; John EM; Roses D; Chung WK; Ostrer H
    Hum Genet; 2013 May; 132(5):523-36. PubMed ID: 23354978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
    Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
    BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.
    Hilbers FS; van 't Hof PJ; Meijers CM; Mei H; Michailidou K; Dennis J; Hogervorst FBL; Nederlof PM; van Asperen CJ; Devilee P
    Int J Cancer; 2020 Nov; 147(10):2708-2716. PubMed ID: 32383162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
    Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
    Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
    Girard E; Eon-Marchais S; Olaso R; Renault AL; Damiola F; Dondon MG; Barjhoux L; Goidin D; Meyer V; Le Gal D; Beauvallet J; Mebirouk N; Lonjou C; Coignard J; Marcou M; Cavaciuti E; Baulard C; Bihoreau MT; Cohen-Haguenauer O; Leroux D; Penet C; Fert-Ferrer S; Colas C; Frebourg T; Eisinger F; Adenis C; Fajac A; Gladieff L; Tinat J; Floquet A; Chiesa J; Giraud S; Mortemousque I; Soubrier F; Audebert-Bellanger S; Limacher JM; Lasset C; Lejeune-Dumoulin S; Dreyfus H; Bignon YJ; Longy M; Pujol P; Venat-Bouvet L; Bonadona V; Berthet P; Luporsi E; Maugard CM; Noguès C; Delnatte C; Fricker JP; Gesta P; Faivre L; Lortholary A; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Servant N; Boland A; Mazoyer S; Deleuze JF; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Int J Cancer; 2019 Apr; 144(8):1962-1974. PubMed ID: 30303537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Sinilnikova OM; McGuffog L; Healey S; Nevanlinna H; Heikkinen T; Simard J; Spurdle AB; Beesley J; Chen X; ; Neuhausen SL; Ding YC; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Peissel B; Bonanni B; Viel A; Bernard L; Radice P; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai PL; Rennert G; Lejbkowicz F; Andrulis IL; Ozcelik H; Glendon G; ; Gerdes AM; Thomassen M; Sunde L; Caligo MA; Laitman Y; Kontorovich T; Cohen S; Kaufman B; Dagan E; Baruch RG; Friedman E; Harbst K; Barbany-Bustinza G; Rantala J; Ehrencrona H; Karlsson P; Domchek SM; Nathanson KL; Osorio A; Blanco I; Lasa A; Benítez J; Hamann U; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; van der Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; van Roozendaal CE; ; Peock S; Cook M; Frost D; Oliver C; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Cole T; Hodgson S; ; Godwin AK; Stoppa-Lyonnet D; Buecher B; Léoné M; Bressac-de Paillerets B; Remenieras A; Caron O; Lenoir GM; Sevenet N; Longy M; Ferrer SF; Prieur F; ; Goldgar D; Miron A; John EM; Buys SS; Daly MB; Hopper JL; Terry MB; Yassin Y; ; Singer C; Gschwantler-Kaulich D; Staudigl C; Hansen Tv; Barkardottir RB; Kirchhoff T; Pal P; Kosarin K; Offit K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Suttner C; Schönbuchner I; Gadzicki D; Caldes T; de la Hoya M; Pooley KA; Easton DF; Chenevix-Trench G;
    Hum Mol Genet; 2009 Nov; 18(22):4442-56. PubMed ID: 19656774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
    Lee A; Mavaddat N; Wilcox AN; Cunningham AP; Carver T; Hartley S; Babb de Villiers C; Izquierdo A; Simard J; Schmidt MK; Walter FM; Chatterjee N; Garcia-Closas M; Tischkowitz M; Pharoah P; Easton DF; Antoniou AC
    Genet Med; 2019 Aug; 21(8):1708-1718. PubMed ID: 30643217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
    Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
    Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
    de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
    Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
    PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort.
    Akter H; Sultana N; Martuza N; Siddiqua A; Dity NJ; Rahaman MA; Samara B; Sayeed A; Basiruzzaman M; Rahman MM; Rashidul Hoq M; Amin MR; Baqui MA; Woodbury-Smith M; Uddin KMF; Islam SS; Awwal R; Berdiev BK; Uddin M
    BMC Med Genet; 2019 Sep; 20(1):150. PubMed ID: 31477031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
    Saunders EJ; Dadaev T; Leongamornlert DA; Al Olama AA; Benlloch S; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pasayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau SN; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Teixeira MR; Pandha H; Govindasami K; Muir K; ; ; ; Easton DF; Eeles RA; Kote-Jarai Z
    Br J Cancer; 2016 Apr; 114(8):945-52. PubMed ID: 26964030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.